These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 19815489

  • 1. A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib.
    Choueiri TK, Mosquera JM, Hirsch MS.
    Clin Genitourin Cancer; 2009 Oct; 7(3):E93-4. PubMed ID: 19815489
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.
    Choueiri TK, Lim ZD, Hirsch MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM.
    Cancer; 2010 Nov 15; 116(22):5219-25. PubMed ID: 20665500
    [Abstract] [Full Text] [Related]

  • 3. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network.
    Malouf GG, Camparo P, Oudard S, Schleiermacher G, Theodore C, Rustine A, Dutcher J, Billemont B, Rixe O, Bompas E, Guillot A, Boccon-Gibod L, Couturier J, Molinié V, Escudier B.
    Ann Oncol; 2010 Sep 15; 21(9):1834-1838. PubMed ID: 20154303
    [Abstract] [Full Text] [Related]

  • 4. An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib.
    Pwint TP, Macaulay V, Roberts IS, Sullivan M, Protheroe A.
    Urol Oncol; 2011 Sep 15; 29(6):821-4. PubMed ID: 19962921
    [Abstract] [Full Text] [Related]

  • 5. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.
    Liu YC, Chang PM, Liu CY, Yang CY, Chen MH, Pan CC, Chen MH.
    Jpn J Clin Oncol; 2011 Nov 15; 41(11):1277-81. PubMed ID: 21965162
    [Abstract] [Full Text] [Related]

  • 6. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, Billis A, Hicks J, De Marzo AM, Reuter VE, Ladanyi M.
    Am J Surg Pathol; 2007 Aug 15; 31(8):1149-60. PubMed ID: 17667536
    [Abstract] [Full Text] [Related]

  • 7. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT, Cheng L.
    Am J Surg Pathol; 2013 Jun 15; 37(6):804-15. PubMed ID: 23598965
    [Abstract] [Full Text] [Related]

  • 8. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas.
    Parihar A, Tickoo SK, Kumar S, Arora VK.
    Int J Surg Pathol; 2015 May 15; 23(3):234-7. PubMed ID: 25519951
    [Abstract] [Full Text] [Related]

  • 9. A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib.
    Numakura K, Tsuchiya N, Yuasa T, Saito M, Obara T, Tsuruta H, Narita S, Horikawa Y, Satoh S, Habuchi T.
    Int J Clin Oncol; 2011 Oct 15; 16(5):577-80. PubMed ID: 21161315
    [Abstract] [Full Text] [Related]

  • 10. Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager.
    Sudour-Bonnange H, Leroy X, Chauvet MP, Classe M, Robin PM, Leblond P.
    Pediatr Blood Cancer; 2014 Sep 15; 61(9):1698-700. PubMed ID: 24585574
    [Abstract] [Full Text] [Related]

  • 11. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R.
    Pediatr Dev Pathol; 2005 Sep 15; 8(2):168-80. PubMed ID: 15747097
    [Abstract] [Full Text] [Related]

  • 12. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
    Koie T, Yoneyama T, Hashimoto Y, Kamimura N, Kusumi T, Kijima H, Ohyama C.
    Int J Urol; 2009 Mar 15; 16(3):333-5. PubMed ID: 19298350
    [Abstract] [Full Text] [Related]

  • 13. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
    Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P.
    Am J Surg Pathol; 2013 Aug 15; 37(8):1150-63. PubMed ID: 23715164
    [Abstract] [Full Text] [Related]

  • 14. Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.
    Hedgepeth RC, Zhou M, Ross J.
    J Pediatr Hematol Oncol; 2009 Aug 15; 31(8):602-4. PubMed ID: 19636262
    [Abstract] [Full Text] [Related]

  • 15. The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.
    Zhu QQ, Wang ZQ, Zhu WR, Chen WX, Wu JT.
    Acta Radiol; 2013 Apr 01; 54(3):355-62. PubMed ID: 23446748
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L, Hayashi M, Guida E, Ooki A, Munari E, Jabboure FJ, Dinalankara W, Raza A, Netto GJ, Hoque MO, Argani P.
    Hum Pathol; 2017 Sep 01; 67():18-29. PubMed ID: 28411178
    [Abstract] [Full Text] [Related]

  • 17. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM, Dal Cin P, Mertz KD, Perner S, Davis IJ, Fisher DE, Rubin MA, Hirsch MS.
    Diagn Mol Pathol; 2011 Sep 01; 20(3):129-37. PubMed ID: 21817901
    [Abstract] [Full Text] [Related]

  • 18. Persistent complete response after single-agent sunitinib treatment in a case of TFE translocation positive relapsed metastatic pediatric renal cell carcinoma.
    Chowdhury T, Prichard-Jones K, Sebire NJ, Bier N, Cherian A, Sullivan MO, O'Meara A, Anderson J.
    J Pediatr Hematol Oncol; 2013 Jan 01; 35(1):e1-3. PubMed ID: 22995920
    [Abstract] [Full Text] [Related]

  • 19. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
    Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A.
    Am J Clin Pathol; 2012 May 01; 137(5):761-8. PubMed ID: 22523215
    [Abstract] [Full Text] [Related]

  • 20. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D, Roy S, Quiroga-Garza G, Cieply K, Mahaffey AL, Bastacky S, Dhir R, Parwani AV.
    Diagn Pathol; 2015 Sep 29; 10():179. PubMed ID: 26415891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.